https://massachusettsweekly.com/article/912934001-walker-s-gymnastics-dance-captures-massachusetts-state-championship-signaling-new-era-of-growth-in-lowell Massachusetts Weekly en PressRelease 2026-05-15T23:02:07+00:00 Walker’s Gymnastics & Dance Captures Massachusetts State Championship, Signaling New Era of Growth in Lowell https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24858378-coach-carlos-1163x641.jpeg https://massachusettsweekly.com/article/912827325-oxeia-biopharmaceuticals-named-most-innovative-mtbi-company-2026 Massachusetts Weekly en PressRelease 2026-05-15T14:00:00+00:00 OXEIA BIOPHARMACEUTICALS NAMED MOST INNOVATIVE mTBI COMPANY 2026 https://massachusettsweekly.com/article/912905115-vibesies-launches-ai-native-hosting-platform-built-around-vibe-coding Massachusetts Weekly en PressRelease 2026-05-15T13:00:00+00:00 Vibesies Launches AI-Native Hosting Platform Built Around Vibe Coding https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24857513-vibesies-com-hp-15-202605150016-2400x1350.png https://massachusettsweekly.com/article/913091483-korro-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Massachusetts Weekly en PressRelease 2026-05-15T20:05:00+00:00 Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://massachusettsweekly.com/article/913091515-candel-therapeutics-reports-extended-clinical-benefit-over-multiple-clinical-endpoints-in-patients-from-phase-3-trial-of-aglatimagene-besadenovec Massachusetts Weekly en PressRelease 2026-05-15T20:05:00+00:00 Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://massachusettsweekly.com/article/913091481-acrivon-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Massachusetts Weekly en PressRelease 2026-05-15T20:00:00+00:00 Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg https://massachusettsweekly.com/article/908369038-aifchem-enhances-drug-discovery-as-a-reliable-innovative-chiral-building-blocks-solution-provider Massachusetts Weekly en PressRelease 2026-05-15T05:18:53+00:00 AiFChem Enhances Drug Discovery as a Reliable Innovative Chiral Building Blocks Solution Provider https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841277-reliable-innovative-chiral-buil-968x733.png https://massachusettsweekly.com/article/913020523-microbot-medical-to-hold-analysts-and-investors-conference-call-to-review-recent-progress-executive-team-will-be-joined-by-current-users-of-the Massachusetts Weekly en PressRelease 2026-05-15T13:56:07+00:00 Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://massachusettsweekly.com/article/913020465-ai-and-advanced-diagnostics-transform-cancer-detection-market-amid-rising-healthcare-investment Massachusetts Weekly en PressRelease 2026-05-15T13:49:09+00:00 AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://massachusettsweekly.com/article/913020272-flywire-continues-execution-on-buyback-plan-through-direct-repurchase-agreement Massachusetts Weekly en PressRelease 2026-05-15T13:00:00+00:00 Flywire Continues Execution on Buyback Plan Through Direct Repurchase Agreement https://ml.globenewswire.com/media/9b1123f3-5f90-4036-ab7b-c4c3d1f5491b/small/flywire-logo-jpg.jpg https://massachusettsweekly.com/article/913003419-lifeward-reports-first-quarter-2026-financial-results Massachusetts Weekly en PressRelease 2026-05-15T12:00:00+00:00 Lifeward Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg https://massachusettsweekly.com/article/913003429-electra-ai-and-iron-horse-acquisition-ii-corp-nasdaq-irho-announce-filing-of-registration-statement-on-form-s-4-with-the-sec-in-connection-with Massachusetts Weekly en PressRelease 2026-05-15T12:00:00+00:00 ELECTRA AI and Iron Horse Acquisition II Corp. (Nasdaq: IRHO) Announce Filing of Registration Statement on Form S-4 with the SEC in Connection with their Proposed Business Combination https://ml.globenewswire.com/media/NWU0NmI5NDUtM2FhYS00N2I4LTlhYzItMjgxMThjMmI2M2VmLTEzMjI5MjctMjAyNi0wNS0xNS1lbg==/tiny/ELECTRA-AI.png https://massachusettsweekly.com/article/913003157-immuneering-reports-first-quarter-2026-financial-results-and-provides-business-updates Massachusetts Weekly en PressRelease 2026-05-15T11:35:00+00:00 Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg https://massachusettsweekly.com/article/913003147-kymera-therapeutics-announces-presentations-on-kt-621-a-first-in-class-oral-stat6-degrader-at-the-society-for-investigative-dermatology-and Massachusetts Weekly en PressRelease 2026-05-15T11:00:00+00:00 Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://massachusettsweekly.com/article/913003191-ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Weekly en PressRelease 2026-05-15T11:00:00+00:00 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://massachusettsweekly.com/article/912321406-cfo-leadership-launches-cfo-bootcamp-an-executive-program-to-transform-finance-leaders-into-enterprise-architects Massachusetts Weekly en PressRelease 2026-05-14T14:15:00+00:00 CFO Leadership Launches 'CFO Bootcamp,' an Executive Program to Transform Finance Leaders into Enterprise Architects https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24854710-cfo-bootcamp-gen-2295x2869.png https://massachusettsweekly.com/article/912557138-millstone-medical-launches-self-serve-lab-quote-builder-with-published-turnaround-times-four-hour-response-commitment Massachusetts Weekly en PressRelease 2026-05-14T12:45:00+00:00 Millstone Medical Launches Self-Serve Lab Quote Builder with Published Turnaround Times & Four-Hour Response Commitment https://massachusettsweekly.com/article/912017685-tellubase-h1-2026-semi-annual-edition-now-released-by-tellusant Massachusetts Weekly en PressRelease 2026-05-14T12:30:00+00:00 TelluBase H1 2026 Semi-Annual Edition Now Released by Tellusant https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24855746-shane-ezepik-1312x1055.jpeg https://massachusettsweekly.com/article/912885597-flywire-to-attend-upcoming-investor-conferences Massachusetts Weekly en PressRelease 2026-05-14T21:25:20+00:00 Flywire to Attend Upcoming Investor Conferences https://ml.globenewswire.com/media/9b1123f3-5f90-4036-ab7b-c4c3d1f5491b/small/flywire-logo-jpg.jpg https://massachusettsweekly.com/article/912885103-aspen-aerogels-begins-staged-restart-of-east-providence-facility Massachusetts Weekly en PressRelease 2026-05-14T20:30:00+00:00 Aspen Aerogels Begins Staged Restart of East Providence Facility https://ml.globenewswire.com/media/d9832b9e-3339-4760-9351-f988900fc3b9/small/aspn-logo-jpg.jpg https://massachusettsweekly.com/article/912865161-cue-biopharma-reports-first-quarter-2026-financial-results-and-recent-strategic-developments Massachusetts Weekly en PressRelease 2026-05-14T20:07:28+00:00 Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://massachusettsweekly.com/article/912844455-tive-reaches-100-million-in-booked-arr Massachusetts Weekly en PressRelease 2026-05-14T17:06:35+00:00 Tive Reaches $100 Million in Booked ARR https://ml.globenewswire.com/media/6f1b8681-efee-4d3f-8837-8e34b54e3fbe/small/tivelogo-jpg.jpg https://massachusettsweekly.com/article/912671427-lowell-summer-music-series-announces-full-lineup-for-36th-season Massachusetts Weekly en PressRelease 2026-05-14T04:52:54+00:00 Lowell Summer Music Series Announces Full Lineup for 36th Season https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24856307-lowell-logo-400x187.png https://massachusettsweekly.com/article/912825447-tecomet-and-orchid-complete-transaction-creating-a-scaled-global-manufacturing-platform Massachusetts Weekly en PressRelease 2026-05-14T16:00:00+00:00 Tecomet and Orchid Complete Transaction, Creating a Scaled Global Manufacturing Platform https://ml.globenewswire.com/media/ZTdkZGI5NjAtMTAyNS00ZTk3LTg2NjgtM2I4Y2IyNGJiNTUxLTUwMDE1NzE3MC0yMDI2LTA1LTE0LWVu/tiny/Tecomet.png https://massachusettsweekly.com/article/912825550-imviva-biotech-presents-data-demonstrating-durable-clinical-responses-from-ongoing-phase-1-2-study-of-cta313-in-systemic-lupus-erythematosus-at-asgct Massachusetts Weekly en PressRelease 2026-05-14T15:43:11+00:00 Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026 https://ml.globenewswire.com/media/YTAyNGM0NGQtNjE0YS00ZmY2LTgxZTktNWRjZjY3M2QzZDM4LTEzMTkxMjUtMjAyNi0wNS0xNC1lbg==/tiny/Imviva-US-Holdings-LLC.png https://massachusettsweekly.com/article/912825544-zapata-quantum-to-present-alongside-fortune-500-and-quantum-leaders-at-upcoming-investor-and-industry-conferences Massachusetts Weekly en PressRelease 2026-05-14T15:40:56+00:00 Zapata Quantum to Present Alongside Fortune 500 and Quantum Leaders at Upcoming Investor and Industry Conferences https://ml.globenewswire.com/media/56af279d-d179-411c-82ab-b1ba4f7f9b20/small/blank-logo-jpg.jpg https://massachusettsweekly.com/article/912825451-ai-technology-investment-surges-to-297-billion-globally-as-enterprise-deployment-accelerates-toward-production-scale Massachusetts Weekly en PressRelease 2026-05-14T15:18:59+00:00 AI Technology Investment Surges to $297 Billion Globally as Enterprise Deployment Accelerates Toward Production Scale https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://massachusettsweekly.com/article/912807389-tessera-therapeutics-showcases-new-preclinical-data-advancing-in-vivo-program-in-sickle-cell-disease-and-car-t-applications-at-the-american-society-of Massachusetts Weekly en PressRelease 2026-05-14T14:20:08+00:00 Tessera Therapeutics Showcases New Preclinical Data Advancing In Vivo Program in Sickle Cell Disease and CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting https://ml.globenewswire.com/media/f24875fb-efec-43e6-8b98-2da3edea398a/small/picture1-jpg.jpg https://massachusettsweekly.com/article/912806237-heilind-electronics-expands-circuit-protection-portfolio-with-optifuse-partnership Massachusetts Weekly en PressRelease 2026-05-14T14:00:00+00:00 Heilind Electronics Expands Circuit Protection Portfolio with OptiFuse Partnership https://ml.globenewswire.com/media/dbd794ad-7ff1-4038-b1e7-d57ced923a83/medium/optifuse.jpg https://massachusettsweekly.com/article/912806032-progress-agentic-rag-named-2026-ai-excellence-award-winner-for-advancing-retrieval-augmented-generation Massachusetts Weekly en PressRelease 2026-05-14T13:00:00+00:00 Progress Agentic RAG Named 2026 AI Excellence Award Winner for Advancing Retrieval-Augmented Generation https://ml.globenewswire.com/media/2a4a917f-af24-458f-b64e-25e5e5cc6c26/small/progress-logo-jpg.jpg https://massachusettsweekly.com/article/912806240-omg-issues-rfp-for-tacsit-configuration-settings-and-services Massachusetts Weekly en PressRelease 2026-05-14T13:00:00+00:00 OMG Issues RFP for TACSIT Configuration Settings and Services https://ml.globenewswire.com/media/OTg1MjlkM2MtNjI3Ni00MzQ3LWIzYmUtMGIwZDVjNmI2NTkxLTEyNjQwNDItMjAyNi0wNS0xNC1lbg==/tiny/Object-Management-Group-SDO.png https://massachusettsweekly.com/article/912806366-cj-biomaterials-launches-new-home-compostable-all-pha-extrusion-coating-resin-for-paper-food-serviceware Massachusetts Weekly en PressRelease 2026-05-14T13:00:00+00:00 CJ Biomaterials Launches New Home Compostable all-PHA Extrusion Coating Resin for Paper Food Serviceware https://ml.globenewswire.com/media/5dbaaccd-ff7a-4d66-8c07-19059a6bd89e/medium/compostable-coffee-cup.jpg https://massachusettsweekly.com/article/912806984-biogen-completes-acquisition-of-apellis-pharmaceuticals Massachusetts Weekly en PressRelease 2026-05-14T12:35:00+00:00 Biogen Completes Acquisition of Apellis Pharmaceuticals https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://massachusettsweekly.com/article/912787448-microbot-medical-successfully-transitions-to-commercial-operations-as-it-records-revenue-resulting-from-its-limited-market-release-during-the-first Massachusetts Weekly en PressRelease 2026-05-14T12:30:00+00:00 Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026 https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://massachusettsweekly.com/article/912787541-hycu-wakes-up-backup-with-air-launch-adds-new-ai-capabilities-across-protected-systems-of-record-within-its-market-leading-r-cloud-resilience Massachusetts Weekly en PressRelease 2026-05-14T12:30:00+00:00 HYCU® Wakes up Backup with aiR™; Launch Adds New AI Capabilities Across Protected Systems of Record Within Its Market-leading R-Cloud Resilience Platform https://ml.globenewswire.com/media/OTk3OTA3NDMtZDYxMC00NGY1LWJlMGYtMDQ0M2M0NGFkZjQyLTEyMDU5NTEtMjAyNi0wNS0xNC1lbg==/tiny/HYCU-Inc-.png https://massachusettsweekly.com/article/912788087-vor-bio-announces-publication-of-interim-analysis-of-teligan-a-china-phase-3-trial-of-telitacicept-in-iga-nephropathy-in-the-new-england-journal-of Massachusetts Weekly en PressRelease 2026-05-14T12:30:00+00:00 Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png https://massachusettsweekly.com/article/912786615-candel-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights Massachusetts Weekly en PressRelease 2026-05-14T12:05:00+00:00 Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://massachusettsweekly.com/article/912786697-keros-therapeutics-reports-recent-first-quarter-2026-financial-results Massachusetts Weekly en PressRelease 2026-05-14T12:00:00+00:00 Keros Therapeutics Reports Recent First Quarter 2026 Financial Results https://ml.globenewswire.com/media/baf5be5e-8ec5-4b74-8950-e28c4888b29c/small/keros-2-jpg.jpg https://massachusettsweekly.com/article/912786788-acquia-launches-fair-trade-initiative-committing-2-of-every-eligible-partner-deal-to-the-drupal-association Massachusetts Weekly en PressRelease 2026-05-14T12:00:00+00:00 Acquia Launches Fair Trade Initiative, Committing 2% of Every Eligible Partner Deal to the Drupal Association https://ml.globenewswire.com/media/b7cbd5b8-edd2-4291-bbf6-306a92ed650f/small/acquia-logo-png.png https://massachusettsweekly.com/article/912787373-corbus-pharmaceuticals-appoints-pharma-industry-veteran-brent-pfeiffenberger-to-board-of-directors Massachusetts Weekly en PressRelease 2026-05-14T12:00:00+00:00 Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://massachusettsweekly.com/article/912787785-acronis-appoints-jim-tedesco-as-chief-revenue-officer Massachusetts Weekly en PressRelease 2026-05-14T12:00:00+00:00 Acronis Appoints Jim Tedesco as Chief Revenue Officer https://ml.globenewswire.com/media/2d47defd-3e29-47ba-90cd-3bb23a9d1938/medium/acronis-appoints-jim-tedesco-as-chief-revenue-officer.png https://massachusettsweekly.com/article/912788127-merlin-unveils-plans-for-ai-powered-autonomy-for-commercial-cargo-aircraft Massachusetts Weekly en PressRelease 2026-05-14T12:00:00+00:00 Merlin Unveils Plans for AI-Powered Autonomy for Commercial Cargo Aircraft https://ml.globenewswire.com/media/30f04298-e7db-4dfa-9a1e-8c6452cdfce0/small/merlin-logo-jpg.jpg https://massachusettsweekly.com/article/912787101-elevatebio-data-at-asgct-29th-annual-meeting-showcase-expanded-gene-editing-platform-and-services-spanning-new-modalities-ai-discovery-and-lnp Massachusetts Weekly en PressRelease 2026-05-14T11:30:00+00:00 ElevateBio Data at ASGCT 29th Annual Meeting Showcase Expanded Gene Editing Platform and Services Spanning New Modalities, AI Discovery, and LNP Delivery https://ml.globenewswire.com/media/42238eb2-fd1c-4189-bf14-c7026687de5b/small/elevatebiologo-jpg.jpg https://massachusettsweekly.com/article/912787848-merlin-inc-reports-first-quarter-2026-results Massachusetts Weekly en PressRelease 2026-05-14T11:30:00+00:00 Merlin, Inc. Reports First Quarter 2026 Results https://ml.globenewswire.com/media/30f04298-e7db-4dfa-9a1e-8c6452cdfce0/small/merlin-logo-jpg.jpg https://massachusettsweekly.com/article/912786644-eyepoint-announces-third-consecutive-positive-dsmc-recommendation-for-phase-3-wet-amd-trials-for-duravyu-building-confidence-ahead-of-mid-2026 Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://massachusettsweekly.com/article/912786712-destination-xl-group-inc-to-announce-first-quarter-2026-financial-results-on-thursday-may-28-2026 Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 Destination XL Group, Inc. to Announce First Quarter 2026 Financial Results on Thursday, May 28, 2026 https://ml.globenewswire.com/media/6ecdc08b-a991-4864-bec7-55382a7936d8/small/dxl-b-t-2020-jpg.jpg https://massachusettsweekly.com/article/912787126-climb-bio-to-present-new-budoprutug-clinical-data-at-european-hematology-association-eha-2026-congress Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg https://massachusettsweekly.com/article/912787191-pyxis-oncology-reports-first-quarter-2026-financial-results-and-advances-micvo-toward-key-2026-clinical-milestones Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://massachusettsweekly.com/article/912787640-akamai-technologies-announces-intent-to-acquire-layerx-advancing-its-workforce-security-strategy-with-ai-usage-control Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 Akamai Technologies Announces Intent to Acquire LayerX, Advancing Its Workforce Security Strategy with AI Usage Control https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png https://massachusettsweekly.com/article/912787739-camp4-therapeutics-to-present-new-preclinical-data-demonstrating-cmp-002-improves-seizure-threshold-and-severity-in-a-model-of-syngap1-related Massachusetts Weekly en PressRelease 2026-05-14T11:00:00+00:00 CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://massachusettsweekly.com/article/912787248-topline-results-from-phase-2-celia-study-of-diranersen-biib080-first-study-to-show-reduction-in-tau-pathology-and-cognitive-benefit-in-patients Massachusetts Weekly en PressRelease 2026-05-14T10:59:00+00:00 Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://massachusettsweekly.com/article/912767795-editas-medicine-reports-new-preclinical-data-demonstrating-progress-of-edit-401-as-potential-treatment-for-hyperlipidemia-at-the-american-society-of Massachusetts Weekly en PressRelease 2026-05-14T10:01:00+00:00 Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg